External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ISTH 2026
Roche and Genentech at

ISTH 2026

July 11 - June 15
Paris, France
isthcongress.org
We will be contributing to topics related to
Haematology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
11:00 AM
Duration 15mins Paris, France
Major surgeries in people with hemophilia A under NXT007 prophylaxis: experience from NXTAGE Phase I/II study
Nogami K, Ogiwara K, Shimonishi N, Nakajima Y, Osuna M, Mizuno N, Kamei Y, Kobayashi R, Shima M, Chen YC
Haematology | Hemophilia A

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 15mins Paris, France
NXT007 prophylaxis in people with hemophilia A with or without factor VIII inhibitors: Combined analysis of two Phase I/II multiple-ascending-dose studies
Mancuso ME, Shima M, Staber JM, Chen YC, López-Jaime FJ, Shen MC, Ventriglia G, Takeyama M, Schmitt C, Park YS, Kiialainen A, Mizuno N, Niggli M, Miyake T, Matino D, Saito T, Jiménez-Yuste V, Kobayashi R, Hart D, Nogami K
Haematology | Hemophilia A

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:45 AM
Duration 60mins Paris, France
Assessment of the bleeding phenotype normality in people with hemophilia A treated with NXT007 prophylaxis: analysis of all-bleed data comparing with healthy volunteers within the NXTAGE study
Shima M, Miwa T, Kojima K, Iwasaki K, Yoneyama K, Sambe T
Haematology | Hemophilia A

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Paris, France
Indirect treatment comparison of emicizumab versus efanesoctocog alfa prophylaxis in pediatric people with severe hemophilia A
Al-Adwan M, Niggli M, Tobaruela G
Haematology | Hemophilia A

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Paris, France
Mental and emotional impact of emicizumab treatment in people with hemophilia A: post hoc analysis of the HAVEN 3 and 4 Studies
Skinner MW, Lee L, Lim E, Tzeng E, Gao L, Buckner TW
Haematology | Hemophilia A

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Paris, France
Reasons for treatment preference in people with hemophilia A switching from FVIII prophylaxis to emicizumab in the BEYOND ABR study: a detailed analysis
Kruse-Jarres R, Castaman G, Di Minno MND, Stephensen D, Lobet S, Barlera S, Brocchieri C, Jiménez-Yuste V
Haematology | Hemophilia A

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
11:45 AM
Duration 60mins Paris, France
AOZORA: safety and joint health outcomes over 6 years in children with hemophilia A – preliminary report from an early cohort
Shima M, Takedani H, Kitsukawa K, Taki M, Ishiguro A, Nagae C, Nagao A, Ioka A, Hoshiba M, Sugawara Y, Iwasaki K, Nogami K
Haematology | Hemophilia A

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.